Literature DB >> 25440489

Eliminating catheter-associated urinary tract infections in the intensive care unit: is it an attainable goal?

Gail T Tominaga1, Achal Dhupa2, Sonja M McAllister2, Robin Calara2, Stacie A Peters3, Amy Stuck3.   

Abstract

BACKGROUND: Purpose of this study is to determine strategies to decrease catheter-associated urinary tract infection (CAUTI) in intensive care unit (ICU) patients.
METHODS: ICU patients with an indwelling urinary catheter (UC) in one tertiary hospital were monitored for CAUTI. Interventions were implemented sequentially with quarterly data collection. Outcome measures were infection ratio (IR = number of infections/catheter days [CD] × 1000) and device utilization rate (DUR = catheter days/patient days).
RESULTS: CDs and DUR decreased (fiscal year 2008: CD, 11,414; DUR, .85 vs fiscal year 2013: CD, 8,144; DUR, .70). IR increased with suspension of prepackaged baths (IR, 3.2 to 3.5 to 4.9 to 5.0), twice daily UC care (IR, 4.8 to 6.7), emptying UC bags at 400 mL (IR, 6.7 to 9.2). Two-person UC placement (IR, 5.6 to 4.8), physician notification of CAUTI (IR, 6.1 to 4.8), and reinstitution of prepackaged baths and daily UC care (IR, 4.8 to 3.7) decreased CAUTI rates.
CONCLUSIONS: Decreasing CAUTI in the ICU requires diligent monitoring and constant practice re-evaluation. Elimination of CAUTI in the ICU may not be possible.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Catheter-associated urinary tract infection (CAUTI); Indwelling urinary catheter; Intensive care unit; Urinary catheter utilization

Mesh:

Year:  2014        PMID: 25440489     DOI: 10.1016/j.amjsurg.2014.08.013

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Reducing Hospital-Acquired Infections Among the Neurologically Critically Ill.

Authors:  John J Halperin; Stephen Moran; Doriann Prasek; Ann Richards; Charlene Ruggiero; Christina Maund
Journal:  Neurocrit Care       Date:  2016-10       Impact factor: 3.210

2.  Assessment of persistent antimicrobial and anti-biofilm activity of p-HEMA hydrogel loaded with rifampicin and cefixime.

Authors:  Ola Tarawneh; Hadeel Abu Mahfouz; Lama Hamadneh; Ahmad A Deeb; Iyad Al-Sheikh; Wasan Alwahsh; Abdulqader Fadhil Abed
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

3.  Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study.

Authors:  Aina Gomila; Jordi Carratalà; Noa Eliakim-Raz; Evelyn Shaw; Cristian Tebé; Martin Wolkewitz; Irith Wiegand; Sally Grier; Christiane Vank; Nienke Cuperus; Leonard Van den Heuvel; Cuong Vuong; Alasdair MacGowan; Leonard Leibovici; Ibironke Addy; Miquel Pujol
Journal:  Antimicrob Resist Infect Control       Date:  2019-12-03       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.